Abstract
The current position on the “passive smoking” of cannabis is reviewed with particular reference to the analysis of urine. The pharmacokinetics and metabolism of delta-9-tetrahydrocannabinol are first described, followed by a survey of methods used to identify and quantify its metabolites in urine. Published data concerning the appearance of cannabinoids in urine following “passive smoking” of cannabis are compared and the most important factors described. The problems of interpreting the results of the analysis of urine in forensic cases are discussed and a possible means to clarify the position by means of analysing serum is suggested.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- THC:
-
delta-9-tetrahydrocannabinol
- THC-acid:
-
11-nor-9-carboxy-THC
- RIA:
-
radioimmunoassay
- HPLC:
-
high-performance liquid chromatography
References
Agurell S, Halldin M, Johansson E, Lindgren J-E, Ohlsson A, Widman M (1985) A review of recent studies on the pharmacokinetics and metabolism of delta-1-tetrahydrocannabinol, cannabidiol and cannabinol in man. In: Harvey D (ed) Marihuana 84. Proceedings of the Oxford symposium on cannabis. IRL press, Oxford, pp 49–62
Baker TS, Harry JV, Russell JW, Myers RL (1984) Rapid method for the GC/MS confirmation of 11nor-9-carboxy-d9-tetrahydrocannabinol in urine. J Anal Toxicol 8: 255–259
Black DL, Goldberger BA, Isenschmid DS, White SM, Caplan YH (1984) Urine cannabinoid analysis: An integrated multi-method approach. J Anal Toxicol 8: 224–227
Cook CE, Schindler VH, Tallent CR (1981) Radioimmunoassay for a major tetrahydrocannabinol (THC) metabolite, 11-nor-9-carboxy-delta-9-tetrahydrocannabinol ( NCTHC ). Fed Proc Fed Am Soc Exp Biol 40A: 245
Cridland JS, Rottanburg D, Robins AH (1983) Apparent half-life of excretion of cannabinoids in man. Human Toxicol 2: 641–644
Elsohly MA, Elsohly HN, Jones AB, Dimson PA, Wells KE (1983) Analysis of the major metabolite of d9-tetrahydrocannabinol in urine II. A HPLC approach. J Anal Toxicol 7: 262–264
Elsohly MA, Arafat ES, Jones AB (1984) Analysis of the major metabolite of d9-tetrahydrocannabinol in urine III. A GC/ECD procedure. J Anal Toxicol 8: 7–9
Halldin MM, Carlsson S, Kanter SL, Widman M, Agurell S (1982a) Urinary metabolites of delta-1tetrahydrocannabinol in man. Arzneim-Forsch 32: 764–768
Halldin MM, Anderson LKR, Widman M, Hollister LE (1982b) Further urinary metabolites of delta1-tetrahydrocannabinol in man. Arzneim-Forsch 32: 1135–1138
Irving J, Leeb B, Foltz RL, Cook CE, Bursey JT, Willette RE (1984) Evaluation of immunoassays for cannabinoids in urine. J Anal Toxicol 8: 192–196
Jones AB, Elsohly HN, ElSohly MA (1984a) Analysis of the major metabolite of 49-tetrahydrocannabinol in urine V. Cross-reactivity of selected compounds in a radioimmunoassay. J Anal Toxicol 8: 252–254
Jones AB, Elsohly HN, Arafat ES, ElSohly MA (1984b) Analysis of the major metabolite of 49-tetrahydrocannabinol in urine IV. A comparison of five methods. J Anal Toxicol 8: 249–251
Karlsson L, Jonsson J, Aberg K, Roos C (1983) Determination of d9-tetrahydrocannabinol-11-oic acid in urine as its pentafluoropropyl-, pentafluoropropionyl derivative by GC/MS utilising negative ion chemical ionization. J Anal Toxicol 7: 198–202
Law B, Pocock K, Moffat AC (1982) An evaluation of a homogeneous enzyme immunoassay ( Emit) for cannabinoid detection in biological fluids. J Forens Sci Soc 22: 275–281
Law B, Mason PA, Moffat AC, Gleadle RI, King Li (1983) Forensic aspects of metabolism and excretion of cannabinoids following oral ingestion of cannabis resin. J Pharm Pharmacol 36: 289–294
Law B, Mason PA, Moffat AC, King LJ (1984a) A novel 1251 radioimmunoassay for the analysis of d9-tetrahydrocannabinol and its metabolites in human body fluids. J Anal Toxicol 8: 14–17
Law B, Mason PA, Moffat AC, King LJ (1984b) Confirmation of cannabis use by the analysis of d9tetrahydrocannabinol metabolites in blood and urine by combined HPLC and RIA. J Anal Toxicol 8: 19–22
Law B, Mason PA, Moffat AC, King Li, Marks V (1984c) Passive inhalation of cannabis smoke. J Pharm Pharmacol 36: 578–581
Law B, Moffat AC (1985) The influence of the metabolism and elimination of cannabinoids on forensic analysis and interpretation. In: Harvey D (ed) Marihuana 84. Proceedings of the Oxford symposium on cannabis. IRL press, Oxford, pp 197–204
Mason AP, Perez-Reyes M, McBay AJ, Foltz RL (1983) Cannabinoids in plasma after passive inhalation of marijuana smoke. JAMA 249: 475–476
Moffat AC, Williams PL, King LJ (1982) Combined high-performance liquid chromatography and radioimmunoassay method for the analysis of d9-tetrahydrocannabinol and its metabolites in plasma and urine. In: Hawks RL (ed) The analysis of cannabinoids in biological fluids. National Institute on Drug Abuse, Rockville, pp 56–68
Moffat AC (ed) (1986) Clarke’s isolation and identification of drugs, 2nd edn. Pharmaceutical Press, London
Perez-Reyes M, Guiseppi SD, Mason AP, Davis KH (1983) Passive inhalation of marihuana smoke and urinary excretion of cannabinoids. Clin Pharmacol Ther 34: 36–41
Wethe G, Bugge A, Bones T, Morland J, Skuterud A, Steen A (1982) Passive smoking of cannabis. Acta Pharmacol Toxicol 51: Suppl 1, Abstract 21
Whiting JD, Manders WW (1982) Confirmation of a tetrahydrocannabinol metabolite in urine by gas chromatography. J Anal Toxicol 6: 49–52
Williams PL, Moffat AC (1980) Identification in human urine of 49-tetrahydrocannabino1–11-oic acid glucuronide: a tetrahydrocannabinol metabolite. J Pharm Pharmacol 32: 445–448
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag
About this paper
Cite this paper
Moffat, A.C. (1986). Monitoring Urine for Inhaled Cannabinoids. In: Chambers, C.M., Chambers, P.L., Tuomisto, J. (eds) Toxic Interfaces of Neurones, Smoke and Genes. Archives of Toxicology, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71248-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-71248-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16589-7
Online ISBN: 978-3-642-71248-7
eBook Packages: Springer Book Archive